Adam Hutchings

Managing Director

Back to Speakers

Adam is Managing Director of Dolon – an innovative, strategic market access consultancy specialising in rare diseases. A health economist by training, he has over 15 years’ market access experience in consulting and the pharmaceutical industry, including roles at Aventis, GlaxoSmithKline and Baxter Healthcare. He is an expert in healthcare policy relating to pricing, reimbursement, and patient access to orphan drugs and treatments for rare diseases.